ClinicalTrials.Veeva

Menu

Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network (COMPLIANCE-MT)

N

Naval Military Medical University

Status

Enrolling

Conditions

Stroke
Central Nervous System Diseases
Cardiovascular Diseases
Nervous System Diseases
Vascular Diseases
Cerebrovascular Disorders
Brain Diseases

Treatments

Behavioral: Post-hospital management based on WeChat applet
Behavioral: Routine post-hospital follow-up management

Study type

Interventional

Funder types

Other

Identifiers

NCT05963828
COMPLIANCE-MT

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.

Full description

Stroke is the leading cause of death among residents in China, with the characteristics of high morbidity, high mortality, high disability rate, high recurrence rate and so on, which brings huge economic burden to the patients' families and society. Strengthening the comprehensive management of the high-risk population of stroke, improving the medication compliance of patients and the control rate of stroke risk factors play a key role in reducing stroke recurrence.

This study is a multicenter, prospective, randomized, single-blind study, which aims to use the tool of WeChat Mini Programs to realize the post-hospital follow-up management of the high-risk population of stroke. The follow-up time is 12 months. The main measurement result was the change of patients' medication compliance after comprehensive management.

Enrollment

720 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • High-risk population of stroke for hospitalization
  • Modified Rankin Scale score≤ 2
  • Patients or primary caregiver have smart phone and wechat accounts
  • Patients take at least one drug for a long time (antihypertensive, hypoglycemic, lipid-lowering, anticoagulant, antiplatelet drugs)
  • Written informed consent

Exclusion criteria

  • Patients and their families are unable to operate smartphones
  • Having other diseases that interfere with clinical follow-up assessment (such as cancer, dementia, severe mental illness, etc.)
  • Life expectancy is less than 12 months
  • Patients living in the absence of network conditions

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

720 participants in 2 patient groups

Standard group
Other group
Description:
Patients are managed according to the routine methods after enrollment.
Treatment:
Behavioral: Routine post-hospital follow-up management
Experimental group
Experimental group
Description:
Patients are managed by the social network platform.
Treatment:
Behavioral: Post-hospital management based on WeChat applet

Trial contacts and locations

1

Loading...

Central trial contact

Qiao mengting

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems